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Comparative genomic and sequence analysis provides
insight into the molecular functionality of NOD1 and NOD2
 
Amino acids with functional or key structural roles display higher degrees of conservation
 
through evolution. The comparative analysis of protein sequences from multiple species  
and/or between homologous proteins can be highly informative in the identification of key  
structural and functional residues. Residues which in turn provide insight into the molecular  
mechanisms of protein function. We have explored the genomic and amino acid conser-  
vation of the prototypic innate immune genes NOD1 and NOD2. NOD1 orthologs were  
found in all vertebrate species analyzed, whilst NOD2 was absent from the genomes of  
avian, reptilian and amphibian species. Evolutionary trace analysis was used to identify  
highly conserved regions of NOD1 and NOD2 across multiple species. Consistent with  
the known functions of NOD1 and NOD2 highly conserved patches were identified that  
matched the Walker A and B motifs and provided interaction surfaces for the adaptor pro-  
tein RIP2. Other patches of high conservation reflect key structural functions as predicted  
by homology models. In addition, the pattern of residue conservation within the leucine-  
rich repeat (LRR) region of NOD1 and NOD2 is indicative of a conserved mechanism of  
ligand recognition involving the concave surface of the LRRs.  
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INTRODUCTION
NOD1 and NOD2 are prototypical members of the NLR fam-
ily of cytosolic pattern recognition receptors and the human
and murine proteins have been widely studied. Both receptors
respond to different fragments of bacterial peptidoglycan, most
likely through direct binding (1–3) although further confirmation
of this is required (4). In the absence of ligand the C-terminal
leucine-rich repeat (LRR) region contributes to autoinhibition, a
state maintained by interaction with chaperone proteins including
Hsp90 and SGT1 (5, 6). Exposure to ligand results in conforma-
tional rearrangement that permits receptor self-association and
nucleotide binding via highly conserved amino acid motifs in
the central NOD (or NACHT) region (7). This is coupled with
migration to the plasma membrane and caspase activation and
recruitment domain (CARD) mediated interaction with the adap-
tor protein RIP2 and/or CARD9. The net effect is to initiate a
pro-inflammatory response mediated by NFκB and stress-kinase
activated genes.
The functionality of NOD1 and NOD2 has been well character-
ized. Despite this we still have a limited understanding of the mol-
ecular basis of receptor function. At the amino acid level: changes
in NOD2 can lead to an increased susceptibility to inflammatory
disorders such as Crohn’s disease or cause conditions like Blau
Syndrome (8–10); variation in the LRR of NOD1 explains the pref-
erential recognition of tripeptide and tetrapeptide diaminopimelic
acid containing peptidoglycan fragments by human and murine
NOD1 respectively (11, 12); the C-terminus of NOD2 is impor-
tant for membrane localization (13); and that specific patches are
involved in RIP2 interaction (14, 15), Ubiquitin binding (16), and
nucleotide binding and hydrolysis (7).
Amino acids that show high levels of conservation across mul-
tiple orthologs or homologs are indicative of residues with impor-
tant structural or functional roles (17). Consequently comparative
sequence analysis can be highly informative in the identification
of functionally important residues. We have compared the amino
acid sequences of NOD1 and NOD2 across vertebrate species
in order to gain a greater understanding of the key functional
regions of both proteins. Key functional patches, for example those
involved in RIP2 binding and nucleotide binding and hydrolysis
show strong, or even complete, conservation across species. Recog-
nition of ligand is likely to be mechanistically conserved between
both NOD1 and NOD2 and located on the concave surface of
the LRR region and we provide further evidence for the impor-
tance of the C-terminus of NOD1 and NOD2 in the function and
localization of the receptor.
MATERIALS AND METHODS
BIOINFORMATICS, DATABASE SEARCHING, AND EVOLUTIONARY
TRACING
The reference sequences for human NOD1 (NP_006083.1) and
human NOD2 (NP_071445.1) were used as search terms to
retrieve orthologous protein sequences from the NCBI protein
database. Sequences with at least 95% sequence coverage were
retained and collated in FASTA format. Sequences were aligned
using MUSCLE (18) and then manually refined to remove incom-
plete and partial sequences. The resulting alignments were sub-
jected to evolutionary tracing using TraceSuite II (19). Consen-
sus sequence images were generated using WebLogo v3.3 (20).
NetSurfP was used to predict the surface accessibility of indi-
vidual amino acids (21). All molecular structure images were
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created using the PyMOL Molecular Graphics System, v1.5.0.5
Schrödinger, LLC.
To perform a pairwise comparison between the eight terminal
LRRs in NOD1 and NOD2 we manually identified the relevant
LRR sequences from the human, chimpanzee, mouse, cow, ele-
phant, platypus, and coelacanth proteins. The number of identical
residues between each possible pair of repeats where one repeat is
from NOD1 and one repeat is from NOD2 was determined and
these values averaged. The average values were tabulated and color
coded on a sliding scale from green (most similar) to red (least
similar).
HOMOLOGY MODELING
Homology models were built using Modeller v9.8 with the follow-
ing templates: NOD2 CARD1 – ICEBERG CARD [1DGN; (22)];
NOD2 CARD1– NOD1 CARD (2DBD); NOD1 and NOD2 LRRs –
porcine ribonuclease inhibitor LRRs [2BNH; (23)]. Models were
refined and the stereochemistry verified using PROCHECK (24).
PLASMIDS
pUNO-NOD1 and pCMV-NOD2 (25) produce full-length
untagged NOD1 and an N-terminally FLAG tagged NOD2 respec-
tively; pLuc and phrG (Promega) encode Firefly and Renilla
luciferase. Mutant constructs were generated by site-directed
mutagenesis.
LUCIFERASE REPORTER ASSAYS
HEK293 cells were maintained in DMEM (Sigma) supplemented
with 10% FCS, 100µg/ml Penicillin/Streptomycin and 2 mM l-
glutamine at 37°C and 5% CO2. Assays were performed in 96-
well plates and using jetPEI (Polyplus Transfection) cells were
transfected with 0.1 ng of NOD1/2 DNA and 1 ng of pLuc and
phrG in each well. Cells were stimulated with specified concen-
trations of iE-DAP, muramyl dipeptide, or iE-Lys (all Invivo-
gen), concomitant with DNA transfection. Cells were lysed 24 h
post transfection with 1× passive lysis buffer (Promega) and
luminescence measured with a LUMIstar Luminometer (BMG
Labtech). Protein expression was checked 24 h after transfec-
tion of HEK293 cells with 3µg/DNA per well in a six-well
plate without ligand stimulation. Proteins were detected with
either monoclonal anti-FLAG (Sigma) or the NOD1 monoclonal
2A10 (26).
SUBCELLULAR FRACTIONATION
Membrane and cytosolic fractionation of transfected HEK293 cells
was performed using a Subcellular Fractionation Kit (Pierce) as
per the manufacturer’s instructions. An antibody against GAPDH
(Abcam) was used to characterize cytosolic fractions.
RESULTS
NOD1 AND NOD2 POSSESS DIFFERENT EVOLUTIONARY PATTERNS
Orthologs of human NOD1 and NOD2 were retrieved from the
NCBI protein database. NOD1 orthologs were found in a wide
range of mammalian species as well as birds, amphibians, and
fish. Consistent with previous reports NOD2 was widely present
in mammals and fish, but absent from avian and amphibian
genomes (27). No reptilian orthologs were recovered for either
protein. Given the otherwise ubiquitous pattern of NOD1 posses-
sion across vertebrates we examined the genome of the reptilian
anole lizard in release 71 of the ENSEMBL genome database. This
approach successfully identified NOD1 in the anole lizard, but
revealed no evidence of a NOD2 ortholog (Figure 1; Table 1).
Comparing the syntenic positions of NOD1 and NOD2 in a
range of vertebrates confirmed the absence of NOD2 from reptiles
(Figure 1; Table 1).
A closer examination of the syntenic position of Nod1 indi-
cated that for all species investigated, except the frog, Nod1 was
located between Znrf2 (zinc and ring finger 2) and Ggct (gamma-
glutamylcyclotransferase). All three genes either side of Nod1 are
strongly conserved, particularly between mammals (Figure 1A).
The syntenic position of Nod2 showed even greater conserva-
tion across mammals, sharing positions with Brd7 (bromod-
omain containing 7), Nkd1 (naked cuticle homolog 1), Snx20
(sorting nexin 20), Cyld (ubiquitin carboxyl-terminal hydrolase
(sometimes referred to as cylindromatosis), and Sall1 (sal-like
1). The syntenic position is maintained in zebrafish except that
Snx20 has been lost. The chicken and anole lizard retained
the whole genomic cluster except for Nod2; whilst in the frog
only Sall1 and Clyd are located together (Figure 1B). Perform-
ing a whole genome BLAST search and screening the expres-
sion sequence tag database did not detect Nod2 in any of these
organisms, nor in the Zebra Finch or Turkey. This indicates
that in birds, reptiles, and amphibians the Nod2 gene has been
specifically lost.
MAPPING KEY RESIDUES IN NOD1 AND NOD2 BY CROSS-SPECIES
COMPARISONS
NOD1 and NOD2 amino acid sequences were aligned and evolu-
tionary tracing was used to examine the amino acid conservation
at two levels. The first level consisted of residues completely con-
served across all vertebrate species. The second level represented
residues completely conserved in mammals, but not across all
of the non-mammalian sequences. The patterns of conservation
are summarized on the human NOD1 (Figure 2) and NOD2
(Figure 3) amino acid sequences.
Levels of cross-species amino acid conservation were highly
similar for NOD1 and NOD2 (Table 2). Conserved residues were
broadly dispersed across both protein sequences with denser, more
focused, patches seen in the CARD, NACHT, and LRR domains
(Figures 2 and 3). These included motifs of known function such
as the RIP2 binding patch in the NOD1 CARD; the Walker A,
Walker B, and Sensor 1 motifs crucial for nucleotide binding
and hydrolysis in the NACHT; and the LRR consensus repeats
(7, 14, 28). In NOD2 the first 27 residues, the C-terminal region
of CARD1 and also the linker portion between the end of the
winged-helix domain and the start of the regulatory region showed
particularly low patterns of conservation (Figure 3). The second
CARD of NOD2 and three sections of the NOD2 LRRs – A794-
Y821, N872-F903, E962-S991 – showed strong conservation across
mammals, but not when piscine NOD2 was included.
NOD1 and NOD2 show varying degrees of conservation of
the protein interaction motif LxxLL, a motif commonly found in
nuclear receptors. Two LxxLL motifs, beginning at L314 and L592,
are completely conserved across all species of NOD1 (Figure 2).
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FIGURE 1 |The syntenic positions of Nod1 and Nod2 are highly
conserved. The syntenic position of (A) Nod1 and (B) Nod2 were
compared in 12 different vertebrate species. The three adjacent genes
upstream and downstream of Nod1/2 are displayed. Each gene is
represented by an individual block with yellow denoting a position on the
forward strand and green a position on the reverse strand. A space
indicates insufficient information to definitively identify the gene in that
location. The red blocks in (B) indicate the absence of the Nod2 gene from
the frog, anole lizard, and chicken genomes. Gene identities are as follows:
Plekha8 – pleckstrin homology domain containing, family A
(phosphoinositide binding specific) member 8; C7orf41 – chromosome
seven open reading frame 41; znrf2 – zinc and ring finger 2;
Nod1 – nucleotide-binding oligomerization domain containing 1;
Ggct – gamma-glutamylcyclotransferase; Gars – glycyl-tRNA synthetase;
Crhr2 – corticotrophin-releasing hormone receptor 2; Fkbp14 – FK506
binding protein 14; BT.25096 – corticotrophin-releasing factor receptor 2;
E13Rik – RIKEN cDNA 241066E13 gene; Entpd3 – ectonucleoside
triphosphate diphosphohydrolase 3; Efcab1 – EF-hand calcium binding
protein; Eaf1 – ELL-associated factor 1-like; Rpl14 – ribosomal protein L14;
Mettl6 – methyltransferase-like protein 6; Gpatch3 – G patch domain
containing 3; Sacm1l – SAC1 suppressor of actin mutations 1-like;
Fzd1 – frizzled homolog 1; Cdk14 – cyclin-dependent kinase 14;
Brd7 – bromodomain containing 7; Nkd1 – naked cuticle homolog 1;
Snx20 – sorting nexin 20; Nod2 – nucleotide-binding oligomerization
domain containing 1; Cyld – ubiquitin carboxyl-terminal hydrolase;
Sall1 – sal-like 1; Gapdh – glyceraldehydes 3-phosphate dehydrogenase;
Nkx6-2 – uncharacterized protein; Gm6625 – protein Gm6625;
Arl2bp – ADP-ribosylation factor-like 2 binding protein; Rspry1 – ring finger
and SPRY domain containing 1; Fam192a – family with sequence similarity
192, member A; Adcy7 – adenylate cyclase 7.
Human NOD2 contains four LxxLL motifs starting at residues
L57, L407, L554, and L678. The second of these, L407xxLL, is in
the NACHT domain and correlates with the NOD1 motif begin-
ning at L314. Unlike NOD1, none of the NOD2 LxxLL motifs
are completely conserved across all species. However, L407FNLL is
conserved across mammals.
DIFFERENT BIOLOGICAL PROCESSES MERIT DIFFERENT LEVELS OF
RESIDUE CONSERVATION
Manon and colleagues (14) previously identified acidic residues in
the NOD1 CARD (E53, D54, E56) as crucial for interaction with
RIP2. E53 and E54 are completely conserved across all species
(Figures 2 and 4A), whereas E56 is completely conserved only in
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Table 1 | Chromosomal position and ENSEMBL identifier for Nod1 and Nod2 across diverse vertebrate species; n.d., not described.
Species Nod1 Nod2
Chromosome ENSEMBL ID Chromosome ENSEMBL ID
Human 7 ENSG00000106100 16 ENSG00000167207
Chimpanzee 7 ENSPTRG00000019040 16 ENSPTRG00000008106
Cat A2 ENSFCAG00000012184 E2 ENSFCAG00000008505
Dog 14 ENSCAFG00000003074 2 ENSCAFG00000009818
Horse 4 ENSECAG00000013825 3 ENSECAG00000017005
Cow 4 ENSBTAG00000038235 18 ENSBTAG00000020936
Mouse 6 ENSMUSG00000038058 8 ENSMUSG00000055994
Rat 4 ENSRNOG00000010629 19 ENSRNOG00000014124
Frog n.d. ENSXETG00000022012 – –
Anole lizard 6 ENSACAG00000002919 – –
Chicken 2 ENSGALG00000011535 – –
Zebrafish 16 ENSDARG00000036308 7 ENSDARG00000010756
mammals. Closer inspection of the individual sequences shows
that only the fish Takifugu rubripes differs at this position, pos-
sessing a highly conservative aspartic acid substitution. The role
of these residues in NOD1 signaling was previously investigated
using charge-reversal mutations (14). In order to avoid the poten-
tial influence of charge-repulsion effects due to the introduction
of a positive charge we instead mutated each residue to alanine
and tested their ability to activate NFκB-mediated signaling in
response to ligand stimulation. The critical nature of E53 and D54
for NOD1 function was confirmed by the inability of either E53A
or D54A to respond to ligand stimulation. E56A activity however
did not differ significantly from the wild-type (Figure 4B). The
slight reduction observed is likely due to the marginally lower
expression of E56A compared to wild-type NOD1 (Figure 4B
inset). Consequently, the impaired signaling of E56K and also its
failure to interact with RIP2 (14) may be due to electrostatic repul-
sion, rather than indicating a critical role for E56 in RIP2 binding
and NOD1 signaling.
For NOD2 two arginine residues, R38 and R86 in CARD1,
are implicated in the interaction with RIP2 (15). These residues
are completely conserved consistent with a crucial role in NOD2
function (Figure 3). We mapped R38 and R86, as well as the other
completely conserved residues, onto a homology model of NOD2
CARD1 to determine if they associated to the same molecular
surface. R38 and R86 were adjacent to each other and clustered
with the surface-exposed residues D90 and K95, suggesting the
possibility of larger electrostatic interface (Figure 4C). L89, which
forms part of the hydrophobic core, also clustered to this region.
There were fewer conserved residues in NOD2 CARD2 and these
predominantly clustered to the helix 2-helix 3 loop, helix 3, and
the helix 3-helix 4 loop (Figure 4D).
Ubiquitination is important in immune signaling. It regulates
RIG-I signaling (29, 30) and is implicated in regulation of RIP2 sig-
naling (31–33). Recently a competitive interaction between RIP2
and ubiquitin for binding to the NOD1 and NOD2 CARDs has
been reported (16) with E84 and Y88 in NOD1 and I104 and
L200 in NOD2 implicated as important for ubiquitin binding.
E84 is completely conserved in mammals (Figures 2 and 4E) and
only differs in five species of fish in which it is mutated to an
alanine. Y88 is less well conserved, although most substitutions
are for other bulky residues such as phenylalanine and histidine
(Figure 4E). I104 and L200 occupy almost identical positions in
the first and second CARD of NOD2. However, whilst L200 is com-
pletely conserved across mammals, I104 is often substituted for
another hydrophobic residue (Figure 4E). Mapping these residues
on to the structure of the NOD1 CARD and our models of the
NOD2 CARDs indicated that neither NOD2 I104 nor L200 are as
exposed on the molecular surface as E84 and Y88 are in NOD1
(Figures 4A–C). We validated this observation using NetSurfP
which predicted that NOD1 E84 and Y88 are surface-exposed, but
that NOD2 I104 and L200 are buried.
CONSERVATION IN THE LRRs PROVIDES INSIGHT INTO LIGAND
BINDING
Consistent with the repeating modular nature of the LRRs both
NOD1 and NOD2 show increased conservation in this region. This
is greatest around the consensus LRR motif LxxLxLxxNxL (where
L= Leu, Val, Ile, Phe; N=Asn, Cys, Ser, Thr; x= any amino acid;
signature residues underlined) (Figures 2 and 3). We mapped the
completely conserved and mammalian-conserved residues onto
homology models of their respective LRR regions but chose not to
annotate any of signature residues to allow a focus on functional
importance (Figure 5). Both NOD1 and NOD2 show molecular
surfaces more conserved toward the N-terminus of the LRRs and
on a single lateral surface (Figures 5A,B).
Mutagenic studies have identified regions of the LRR impor-
tant for receptor activation (Table 3) (12, 34, 35). Five of the
seven NOD1 residues are completely conserved across all species
(Figures 2 and 5C). H788 is predominantly found as a histidine
in mammals except for the pig where it is a cysteine and the horse,
elephant, West Indian manatee, Northern greater galago, nine-
banded armadillo, and white rhinoceros in which it is a tyrosine.
In the non-mammalian species this residue is substituted by thre-
onine, arginine, valine, and isoleucine. E816 has previously been
implicated in selectivity for preferential activation by ligands with
either tripeptide or tetrapeptide stems (11, 12). Consistent with
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FIGURE 2 | Pattern of cross-species residue conservation in NOD1.
Residues conserved across all NOD1 species checked, or just across
mammals, are highlighted green and purple respectively. Residues are
mapped onto the amino acid sequence for human NOD1. The domain
architecture is highlighted underneath the relevant stretch of sequence as
follows: CARDs – gold; NACHT – dark blue; C-rich region – blue;
Winged-helix – pale blue; LRRs – red. The motifs responsible for RIP2 binding,
the Walker A and B motifs and the Sensor 1 region are all labeled in black
above the relevant sequence. Also labeled above the sequence are LxxLL
motifs [black bars (L1, L2)], residues predicted to be important for ubiquitin
binding (purple asterisks), and residues predicted to be involved in ligand
recognition (blue asterisks).
a role in selectivity this residue was found as either an aspar-
tic acid (26/53 sequences) or a glutamic acid (27/53 residues).
All seven residues previously implicated in NOD2 activation are
conserved across mammals, but not other species (Figures 3 and
5D). In the case of K989 and S991 this is due to the lack of
a single LRR-encoding exon in Actinopterygii orthologs. Map-
ping these residues to the predicted structures revealed clustering
around the edges of the concave surface of the LRR for both
NOD1 and NOD2 (Figures 5C,D). When all conserved residues
are considered the interface extends around the whole concave sur-
face. These residues routinely appear in the second, third, fourth,
and to a lesser extent fifth, variable positions in the consensus
LRR motif (Lx1x2Lx3Lx4x5Nx6L) providing further support for a
crucial functional role (Table 3).
The similar patterns of residue conservation on the concave
surface of NOD1 and NOD2, and the chemical similarities in acti-
vatory ligand, led us to ask exactly how alike these regions of the
two proteins are. To begin we compared the eight terminal LRRs
(LRRs 3–10) from human NOD1 and NOD2 to identify identi-
cal residues on the concave surface. Apart from the LxxLxLxxNxL
motif, only seven identical residues were found and only three of
these – W820, G821, and S846 (NOD1); W907, G908, and S933
(NOD2) – were fully conserved in all examined species of NOD1
and all mammalian NOD2 sequences (Figures 2 and 3). Spatially
these residues are predicted to be in close proximity and may form
a binding site for the shared elements in NOD1 and NOD2 ligands
(Figure 6A). In support of this possibility, the conserved glycine
in NOD2 has been thoroughly investigated as a SNP (G908R)
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FIGURE 3 | Pattern of cross-species residue conservation in NOD2.
Residues conserved across all NOD2 species checked, or just across
mammals, are highlighted green and purple respectively. Residues are
mapped onto the amino acid sequence for human NOD2. The domain
architecture is highlighted underneath the relevant stretch of sequence
as follows: CARDs – gold; NACHT – dark blue; C-rich region – blue;
Winged-helix – pale blue; LRRs – red. The motifs responsible for RIP2
binding, the Walker A and B motifs, the Sensor 1 region and the
regulatory region from residues 664 to 854 are all labeled in black above
the relevant sequence. Also labeled above the sequence are the LxxLL
motifs [black bars (L1, L2, L3, L4)], residues predicted to be important for
interaction with RIP2 (yellow asterisks), ubiquitin binding (purple
asterisks), and residues predicted to be involved in ligand recognition
(blue asterisks).
which predisposes to Crohn’s Disease and reduces the ability of
NOD2 to respond to MDP. In addition, a W907L NOD2 mutant
was generated by Tanabe et al. and was found to eliminate the
response to NOD2 (35). The role of the conserved serine is yet to
be investigated.
We accompanied the search for individual residues in the LRRs
with a broad examination of repeat similarity. The eight terminal
repeats are formed of 28 amino acids each, with the final repeat
showing greater sequence divergence and possibly stabilizing the
end of the domain in a similar way to LRR capping structures
(36). We compared these eight LRRs from the human, chimpanzee,
mouse, cow, elephant, platypus, and coelacanth in order to look
for identical residues. LRR6 was more similar between NOD1
Table 2 | Levels of cross-species amino acid identity for NOD1 and
NOD2.
Percentage of identical amino acids
All species Mammalian sequences
NOD1 19.3 39.8
NOD2 18.3 37.0
and NOD2 than any other set of repeats, presumably reflecting
a conserved functional role (Figure 6B). This repeat contains the
WG motif discussed above and the adjacent LRR7 contains the
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FIGURE 4 | Amino acid conservation in the NOD1 and NOD2 CARDs.
Cartoon and surface representations of NOD1 CARD (A), NOD2
CARD1 (C), and NOD2 CARD2 (D) showing amino acids conserved across
all species (green) and conserved across mammals (pink). In each panel
the top and bottom images are related by a 180° rotation around the
vertical axis. The left and right images are cartoon and surface
representations of the same view respectively. Residues previously
implicated in interaction with RIP2 (NOD1 – E53, D54, E56; NOD2 – R38,
R36) or in the process of ubiquitination (NOD1 – E84, Y88; NOD2 – I104,
L200) are labeled and presented as spheres. Conservation is mapped onto
an experimental NOD1 structure (PDB ID: 2DBD) and homology models of
the NOD2 CARDs. (B) Differential contributions to receptor activation.
NFκB luciferase reporter assays were performed in HEK293 cells using
wild-type (WT) NOD1, E53A, D54A, and E56A constructs. DNA
(0.1 ng/well) and varying concentrations of stimulatory (i.e., DAP) or control
(i.e., Lys) ligands were transfected into 96-well plates. After 24 h cells were
lysed and NFκB activity determined. Results show the average of four
independent experiments and **p<0.005. Error bars indicate SEM.
Immunoblots (1.5µg DNA/well in a six-well plate) were lysed after 24 h and
probed with the specified antibodies to determine expression levels of
NOD1 WT and mutant constructs. Immunoblots are representative of at
least three separate experiments. (E) Patterns of conservation in the
primary sequence observed around residues implicated in the
ubiquitination of the CARDs. Residues are colored according to
hydrophobicity (green – hydrophobic; blue – hydrophilic). Sequence images
were generated using WebLogo 3.3 (20).
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FIGURE 5 | Amino acid conservation in the NOD1 and NOD2 LRRs.
Surface representations of homology models of the NOD1 (A) and NOD2
LRRs (B) showing residues conserved across species (green) or just across
mammals (pink). For clarity signature residues conserved in the consensus
LRR repeat LxxLxLxxNxL (signature residues L and N) are not represented.
The left and right images in (A,B) are related by a 180° rotation around the
vertical axis. Cartoon representations of the concave surface of the NOD1 (C)
and NOD2 (D) LRRs highlight the spatial relationships of residues likely to be
involved in ligand detection. The side chains of residues previously implicated
in ligand detection and receptor activation are represented as spheres and
labeled appropriately except for G792, G818 (NOD1), and G879, G908
(NOD2). Residues are colored as for (A,B).
Table 3 | Residues contributing to potential ligand binding patches on NOD1 and NOD2.
Residues previously implicated by mutagenesisa Conserved residues with a potential to form part of a ligand binding interface
NOD1 H788, K790, G792, E816, G818, W820, W874 Y679, L706, D711, N712, R734, S736, V737, I757, G762, Y764, G821, S846, A848,
T876, T897, W902, I904, E928, C930, G933
NOD2 G879, W907, G908, V935, E959, K989, S991 H766, K768, T770, A794, Q796, D798, A819, Y821, R823, F851, N852, R877, N880,
F903, G905, W931, S933, G936, E958, C960, E962, E963, E1015, W1017
aFrom (12, 35).
conserved serine. Comparison across LRRs show that none of these
conserved residues are commonly found in this position in multi-
ple repeats and so are unlikely to be structurally important to the
domain fold (Figure 6C).
DISRUPTION OF CONSERVED C-TERMINAL RESIDUES ALTERS
RECEPTOR SIGNALING AND MEMBRANE LOCALIZATION
NOD1 and NOD2 are both targeted to the plasma membrane fol-
lowing activation (13, 26, 37, 38). The NOD2 1007fsincC Crohn’s
Disease susceptibility polymorphism lacks the last 33 amino acids
and doesn’t membrane localize (13). In fact the terminal three
leucine residues appear important for localization. The final 33
amino acids of mammalian NOD1 and mammalian NOD2 show
that the final LRR in both proteins is well conserved (Figure 7A).
Outside this region residue conservation differs between the two
proteins except that both human NOD1 and NOD2 have an EE
motif starting 15 residues before the end of the protein, the second
residue of which is conserved in mammalian NOD1 sequences. A
closer examination of this motif showed that it is in fact highly
conserved in NOD1 and NOD2 for most mammals. In NOD1
only the nine-banded armadillo varies in the first position, which
is substituted for an aspartic acid. With NOD2 the EE motif is
conserved in all mammalian sequences except the star-nosed mole
in which the sequence is AD. In light of this degree of conserva-
tion we mutated both these residues, and also R1037 (conserved
in NOD2 and immediately prior to the terminal LLL motif), in
NOD2 to alanine and assessed the impact on receptor activation
and protein localization following overexpression in HEK293 cells.
All three mutants were significantly impaired in their ability to
respond to muramyl dipeptide stimulation in comparison to the
WT unstimulated protein (Figure 7B; p-values: E1026A= 0.042;
E1027A= 0.025; R1037A= 0.029). However, each mutant also
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FIGURE 6 | Patterns of LRR conservation between NOD1 and NOD2
support a conserved ligand binding surface. (A) Other than the
signature residues in the LxxLxLxxNxL motif only three
residues – W820, G821, and S846 (NOD1); W907, G908, and S933
(NOD2) – are conserved across all examined species of NOD1 and all
mammalian NOD2 sequences. The likely spatial position of these
residues on the concave surface of NOD1 is shown. The residue
sidechains are represented as red sticks. (B) Heat map representation of
the relative similarity of the eight terminal LRR repeats in NOD1 and
NOD2 from the human, chimpanzee, mouse, cow, elephant, platypus,
and coelacanth. The number in each box represents the average number
of identical residues in a cross-species pairwise comparison between
the relevant LRR motifs. Boxes are colored on a graded scale from green
(most similar) down to red (least similar). (C) The three residues
(highlighted red) are found in the X3, X4, and X5 position of the LRR
consensus motif. These positions are populated by a wide range of
different amino acids (highlighted yellow). K989 and S991 (highlighted in
purple), two residues in human NOD2 implicated in ligand recognition
and receptor activation, are located in a region of the protein missing in
the Actinopterygii due to an exon deletion.
displayed a reduction in basal signaling in the absence of MDP.
This resulted in the following approximate fold-increase in signal-
ing for each construct: WT (threefold), E1026A (fourfold), E1027A
(fivefold), and R1037A (threefold). As such, none of the mutants
show impairment in their relative responses to ligand stimulation.
Despite their ability to still respond to MDP neither E1027A nor
R1037A were recruited to the plasma membrane (Figure 7C).
DISCUSSION
Comparative biology has the potential to rationalize and explain
experimental observations and identify potentially key functional
amino acids. We have performed, to our knowledge, the first com-
prehensive cross-species comparative analysis of the amino acid
composition of NOD1 and NOD2. Reassuringly we found that
regions of NOD1 and NOD2 already reported to provide essential
functional roles showed increased, or even complete, conservation
across species. Most notably these related to the Walker A and B
motifs in the NACHT domain, the consensus region of the LRR
motifs and residues crucial for interaction with the downstream
adaptor protein RIP2 in NOD1 and NOD2.
Our analysis identified conserved LxxLL motifs in NOD1 and
mammalian NOD2. LxxLL motifs are routinely used in nuclear
receptors and form a key part of the nuclear receptor box (39).
The precise function of the LxxLL motifs in NOD1 and NOD2 is
currently unknown, however, it is highly unlikely that either NOD1
or NOD2 has an as yet unidentified nuclear role. The LxxLL motif
has previously been reported in NACHT domains, including those
of various plant R proteins which are divergently evolved relatives
of the vertebrate NLR family (40, 41). In addition, oligomeriza-
tion of the NLR protein CIITA utilizes an LxxLL motif in the
NACHT domain (42). It is plausible that the conserved LxxLL
motifs beginning at L314 (NOD1) and L407 (NOD2) provide a
similar functionality.
The pattern of residue conservation in the LRRs of NOD1 and
NOD2 is highly similar and points strongly toward a conserved
mechanism of ligand binding and/or recognition on the concave
surface of the LRRs. The mapping of these key residues to the con-
cave surface is consistent with earlier work (12, 35), however, we
have shown here that this interface may be more extensive than
previously thought. In both NOD1 and NOD2 highly conserved
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FIGURE 7 |The impact of mutation of conserved residues between the
C-terminus of human NOD1 and NOD2 on receptor function.
(A) Alignment of the terminal 33 amino acids of human NOD1 and NOD2.
Residues highlighted in cyan are conserved across mammals in the relevant
protein. The consensus sequence highlights residues found in the termini
of both human NOD1 and NOD2. (B) NFκB luciferase reporter assays were
performed in HEK293 cells using wild-type pCMV-NOD2 and the point
mutants E1026A, E1027A, and R1037A. DNA (0.1 ng/well) was transfected
into 96-well plates with (black bars) and without (white bars) muramyl
dipeptide (MDP). After 24 h cells were lysed and NFκB activity determined.
Results show the average of three independent experiments and *p<0.05.
Error bars indicate SEM. (C) Subcellular fractionation was performed with
wild-type and mutant NOD2 constructs to separate the cytoplasmic (C) and
membrane-bound (M) fractions. Proteins were identified with the specified
antibodies. Blots are representative of three independent experiments.
residues increase the potential size of this interface and provide
clear candidates for future mutagenesis studies.
Both NOD1 and NOD2 bind peptidoglycan fragments but dis-
criminate between Lys-Type and diaminopimelic acid (DAP)-type
muropeptides (34). This binding specificity is also seen in the Pep-
tidoglycan Recognition Proteins (PGRPs), for which structural
information has been used to identify the residues responsi-
ble for this difference in binding (43, 44). For NOD1 only the
d-isoglutamyl-m-DAP moiety is required for signaling, but the
presence of the preceding alanine enhances this response (34).
In contrast, MDP, which consists of the MurNAc-l-alanine-d-
isoglutamine segment, can signal effectively through NOD2. The
similar ligands, and the similar patterns of conservation on the
concave surface, suggest that the NOD1/2 ancestral gene could
bind a muropeptide. Following gene duplication these binding
sites evolved to permit the binding of distinct ligands by NOD1
and NOD2. We predict in NOD1 and NOD2 a mechanism sim-
ilar to that of the PGRPs, where the comparable muropeptide
ligands are bound in the same orientation but are told apart by
their third peptide. An extra level of subtlety is displayed by the
different species sensitivities of NOD1 to tripeptide and tetrapep-
tide stem lengths (11, 12). We have seen a clear split between the
possession of either an aspartic acid or a glutamic acid residue in
the equivalent position to human NOD1 E816. Indicating NOD1
has consistently evolved to respond preferentially to either tripep-
tide stem lengths (glutamic acid) or tetrapeptide stems (aspartic
acid). Whether this is driven by exposure to particular microbiota
remains unknown.
Unlike NOD1, NOD2 is not ubiquitously present in all species
and the specific loss of the gene in birds, reptiles, and amphib-
ians raises many questions about its evolutionary and functional
roles. For example, what drives gene loss? Is this due to the absence
of specific pathogenic threats in these populations? Interestingly
multiple areas of NOD2 show strong conservation across mam-
mals, but differ in the Actinopterygii orthologs. This is particularly
noticeable in the LRRs. Actinopterygii orthologs of NOD2 are
missing a single LRR-encoding exon which contains two residues
which have been reported to contribute to the human MDP
response, and which will alter the overall fold of the LRR. While the
ability of these orthologs to respond to MDP or other muropep-
tides has not been investigated, it is possible in light of the NOD2
complete gene loss in birds, the anole lizard, and the frog that this
function has also been lost in the actinopterygii.
The patterns of evolutionary conservation observed have
increased the clarity of some functions, such as ligand-mediated
activation, of NOD1 and NOD2. However, they have also raised
questions of other published observations. Previously, Manon et
al. reported that NOD1 E56 was essential for signaling as recep-
tor activity was abrogated following mutation to lysine (14). The
near-complete conservation of E56 across species supports an
important functional role, however, mutating this residue to an
alanine retains signaling, suggesting that at least some mutations
are tolerated and that E56 is not absolutely critical for NOD1 sig-
naling. Mutation of the acidic residues in the NOD1 EDAE motif
will have reduced their spatial occupancy but their predominantly
surface-exposed nature makes it unlikely that the native fold of the
protein will have been perturbed (45). Our comparative analysis
also suggests that the role of ubiquitin in NOD1 and NOD2 sig-
naling may be more complex than previously imagined (16). The
observed cross-species variation in NOD1 Y88 and NOD2 I104
suggests that the role of ubiquitin binding might differ between
species; or that it is the general surface properties of this region, not
the exact residues, that are important. Our homology modeling
suggested that NOD2 I104 and L200 may be buried residues, muta-
tion of which could disrupt the overall fold of the CARD. However,
in the absence of a structure of the NOD2 CARDs this possibility
remains theoretical and awaits experimental confirmation.
We identified a highly conserved di-acidic motif in the C-
terminal region of both NOD1 and NOD2. Mutant NOD2 con-
structs showed reduced signaling compared to unstimulated wild-
type NOD2, but also displayed a reduced basal level of activity.
This resulted in the relative fold-increase for each construct being
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broadly comparable to wild-type NOD2. Despite their ability to
still respond to MDP neither E1027A nor the downstream R1037A
were efficiently recruited to the plasma membrane. Hence mem-
brane recruitment may not be essential for NOD2 signaling, but
might contribute to maximizing the efficiency of signaling. An
earlier study by Barnich and colleagues (13) showed that a dou-
ble EE to GG mutation did not alter membrane localization, or
significantly disrupt NFκB signaling. Coupled with our data this
raises the question of what the actual role of the EE motif is. Its
high level of conservation suggests an important functional role,
but this has yet to be experimentally confirmed and merits further
investigation.
Overall, our work highlights the applicability of comparative
biology and cross-species sequence analysis toward understanding
the molecular basis of innate immune receptor function. It is
an approach that if more widely used could provide extensive
rewards in relation to efficiency savings by readily identifying
suitable targets for functional study. Furthermore, it helps to
provide a rationalization for the results of mutagenic studies
thereby enabling an improved understanding of innate immune
function.
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